To evaluate the impact of silencing tumor cell PRSS3 expression in this model, PC9 cells were stably transduced either with a nontarget control (NT) virus recognizing no human genes, or with one of two lentiviral shRNA knockdown constructs specifically targeting the PRSS3 gene. The gene discussed is PRSS3; the disease is neoplasm.